A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma

BACKGROUND: Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B). However, it often leads to a poor prognosis and decreased hepatic function especially in patients with BCLC substage B2. Lenvat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Satoshi, Fukushima, Taito, Ueno, Makoto, Moriya, Satoshi, Chuma, Makoto, Numata, Kazushi, Tsuruya, Kota, Hirose, Shunji, Kagawa, Tatehiro, Hattori, Nobuhiro, Watanabe, Tsunamasa, Matsunaga, Kotaro, Suzuki, Michihiro, Uojima, Haruki, Hidaka, Hisashi, Kusano, Chika, Suzuki, Motoko, Morimoto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080183/
https://www.ncbi.nlm.nih.gov/pubmed/35525913
http://dx.doi.org/10.1186/s12885-022-09625-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080183/
https://www.ncbi.nlm.nih.gov/pubmed/35525913
http://dx.doi.org/10.1186/s12885-022-09625-x

Ejemplares similares